Health News Headline
Bosulif Approved for Rare Leukemia
WEDNESDAY, Sept. 5 (HealthDay News) -- Bosulif (bosutinib) has been approved by the U.S. Food and Drug Administration to treat chronic myelogenous leukemia (CML), a cancer of the blood and bone marrow that primarily affects older people, the agency said in a news release.Read entire article...
Some others: Nimetazepamum, Valisone, Margesic 3, Métoclopramide, Desvenlafaxin, Achromycin V, Moditen, Cod-Efferalgan, Verladyn, Kalten, Sitagliptina, Tolterodine, ...
Many Cocaine Deaths Determined by Genes, Study Says
WEDNESDAY, Jan. 30 (HealthDay News) -- People with common mutations on two genes have a nearly eightfold increased risk of dying from cocaine abuse, according to a new study.
The mutations affect how dopamine affects brain activity. Dopamine is a chemical messenger that's vital to the function of the central nervous system. Cocaine is known to block transporters in the brain from absorbing dopamine, the Ohio State University researchers said.
The findings, published online in the January issue of the journal Translational Psychiatry, apply primarily to white people. The study authors found that about one in three whites who died of cocaine abuse had these gene mutations.
A different combination of gene mutations affects the risk of cocaine-abuse death in black people, the researchers said in a university news release.Read entire article...